BerandaAVHHL • OTCMKTS
add
AVITA Medical Inc
Tutup sebelumnya
$2,67
Rentang tahun
$1,41 - $3,28
Kapitalisasi pasar
231,24 jt USD
Volume Rata-Rata
105,00
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 19,55 jt | 43,25% |
Biaya operasional | 30,16 jt | 44,75% |
Laba bersih | -16,20 jt | -86,01% |
Margin laba bersih | -82,91 | -29,85% |
Penghasilan per saham | -0,93 | -75,60% |
EBITDA | -13,50 jt | -47,63% |
Tarif pajak efektif | 0,17% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 44,40 jt | -26,14% |
Total aset | 81,05 jt | 0,05% |
Total liabilitas | 68,82 jt | 281,59% |
Total ekuitas | 12,23 jt | — |
Saham yang beredar | 26,22 jt | — |
Harga terhadap nilai buku | 5,67 | — |
Tingkat pengembalian aset | -40,88% | — |
Tingkat pengembalian modal | -54,41% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -16,20 jt | -86,01% |
Kas dari operasi | -7,21 jt | 19,61% |
Kas dari investasi | 7,39 jt | -66,02% |
Kas dari pembiayaan | 1,01 jt | 67,83% |
Perubahan kas bersih | 1,19 jt | -91,12% |
Arus kas bebas | -5,35 jt | 35,08% |
Tentang
Avita Medical is a clinical and commercial company developing and marketing a range of respiratory and regenerative products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
Didirikan
1999
Kantor pusat
Situs
Karyawan
207
